Finnrick - Ensuring a Safer and More Transparent Supply Chain
Dankang BioHealth

Dankang BioHealth

Tirzepatide

Finnrick tested 7 samples of Tirzepatide (GLP-1 and GIP agonist) from Dankang BioHealth between 22 Jan 2026 and 28 Apr 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
Dankang BioHealth
Tirzepatide
Tested 7 Samples
Last test 28 Apr 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Dankang BioHealth

Samples are tested in commercial labs

Tests Count

7

Scores

AVG6.9MIN2.0MAX10.0

Last

28 Apr 2026

First

22 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
28 Apr 2026View7.610mg8.48mg-15.2%99.90%n/a5/1/2026No Label / Silver Crimp / Pink CapLab EPublic
28 Apr 2026View8.020mg19.1mg-4.5%99.90%n/a(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
25 Mar 2026View5.915mg28mg+86.7%99.80%n/a2026/02(no data)Lab GPublic
2 Mar 2026View2.030mg
⚠️ Sample does not contain Tirzepatide
n/a12/23/2025No Label / Gold Crimp / White CapLab EPublic
2 Mar 2026View10.015mg14.3mg-4.7%99.90%n/a12/23/25No Label / Silver Crimp / Blue CapLab EPublic
13 Feb 2026View8.215mg13.3mg-11.3%99.90%
below LOQ
2025/12/25No Label / Silver Crimp / Blue CapLab EPublic
22 Jan 2026View6.620mg18.1mg-9.5%99.90%n/a(no batch ID)No Label / Silver Crimp / Yellow CapLab GPublic